Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a
published in: Journal of NeuroVirology
date of publication: 2014-09-17
Cites articles 64
Date
Title
Article - wd:Q34718135